XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	0,000	0,000	16.10.

Realtime

Geld

Brief

Zeit

0,000

16.10.

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024

Das Instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument TG4 BE0003846632 OXURION N.V. EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument TG4 BE0003846632 OXURION N.V. EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument 5LH0 SE0021181559 GUARD THERAPEUTICS INT.AB EQUITY wird ex Kapitalmassnahme gehandelt am 02.09.2024
The instrument 5LH0 SE0021181559 GUARD THERAPEUTICS INT.AB EQUITY is traded ex capital adjustment on 02.09.2024

Das Instrument HQ10 US00211Y5069 ARCA BIOPHARMA DL-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument HQ10 US00211Y5069 ARCA BIOPHARMA DL-,01 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument FET KYG3307Z1090 FAR EAST CONS. INTL HD-10 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument FET KYG3307Z1090 FAR EAST CONS. INTL HD-10 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument 4QI KYG982771092 XTEP INTL HOL.REGS HD-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument 4QI KYG982771092 XTEP INTL HOL.REGS HD-,01 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument 6LJ US5768101058 MATINAS BIOPH.HLD.DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument 6LJ US5768101058 MATINAS BIOPH.HLD.DL-,001 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument M5L GB00B0MT3Y97 MATTIOLI WOODS PLC LS-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument M5L GB00B0MT3Y97 MATTIOLI WOODS PLC LS-,01 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument EJ7 AU000000ERA9 ENERGY RES. A EQUITY wird ex Kapitalmassnahme gehandelt am 02.09.2024
The instrument EJ7 AU000000ERA9 ENERGY RES. A EQUITY is traded ex capital adjustment on 02.09.2024

Nach der Korrektur – 3 Kupferproduzenten für das Comeback

Kupfer wird oft als „das Gold der Energiewende“ bezeichnet, weil es aufgrund seiner hervorragenden elektrischen Leitfähigkeit eine zentrale Rolle in vielen Technologien spielt, die für nachhaltige Energiesysteme entscheidend sind. Experten gehen aufgrund der Angebotsknappheit von einem Superzyklus aus.

Korrektur als Einstiegschance

Nach Höchstständen im Mai korrigierte das rote Metall stark. Die Abwärtsspirale verstärkte sich in den vergangenen Tagen aufgrund schwacher Konjunkturdaten aus den USA und China. Langfristig könnte sich die aktuell laufende Korrektur als exzellente Einstiegsmöglichkeit herausstellen.

3 Kupferaktien mit hohem Potential

Im neuen, kostenlosen Spezialreport stellen wir drei aussichtsreiche Unternehmen vor, die bei einem weiteren Anstieg überproportional profitieren könnten.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Report herunterladen

Zeit	Aktuelle Nachrichten
Mo	ENERGY RESOURCES OF AUSTRALIA LIMITED: Update on Legal Proceedings
24.10.	ENERGY RESOURCES OF AUSTRALIA LIMITED: Quarterly Activities Report
24.10.	ENERGY RESOURCES OF AUSTRALIA LIMITED: Quarterly Cashflow Report - Appendix 4C
23.10.	ENERGY RESOURCES OF AUSTRALIA LIMITED: Change in substantial holding
23.10.	ENERGY RESOURCES OF AUSTRALIA LIMITED: Appendix 3Y - Brad Welsh

Zeit

Aktuelle Nachrichten

ENERGY RESOURCES OF AUSTRALIA LIMITED: Update on Legal Proceedings

24.10.

ENERGY RESOURCES OF AUSTRALIA LIMITED: Quarterly Activities Report

24.10.

ENERGY RESOURCES OF AUSTRALIA LIMITED: Quarterly Cashflow Report - Appendix 4C

23.10.

ENERGY RESOURCES OF AUSTRALIA LIMITED: Change in substantial holding

23.10.

ENERGY RESOURCES OF AUSTRALIA LIMITED: Appendix 3Y - Brad Welsh

Zeit	Aktuelle Nachrichten
24.10.	FE CONSORT INTL (00035): NEXT DAY DISCLOSURE RETURN
30.09.	FE CONSORT INTL (00035): CONTINUING CONNECTED TRANSACTIONS HOTEL MANAGEMENT CONTRACTS AND TRADEMARK LICENSE AGREEMENTS IN RELATION TO HOTELS IN MALAYSIA
23.09.	FE CONSORT INTL (00035): SETTLEMENT OF CONSENT SOLICITATION - U.S.$360,000,000 SENIOR GUARANTEED PERPETUAL CAPITAL NOTES ISSUED BY FEC FINANCE LIMITED ...
19.09.	FE CONSORT INTL (00035): FORM OF ELECTION
17.09.	FE CONSORT INTL (00035): RESULTS OF CONSENT SOLICITATION - U.S.$360,000,000 SENIOR GUARANTEED PERPETUAL CAPITAL NOTES ISSUED BY FEC FINANCE LIMITED AND ...

Zeit

Aktuelle Nachrichten

24.10.

FE CONSORT INTL (00035): NEXT DAY DISCLOSURE RETURN

30.09.

FE CONSORT INTL (00035): CONTINUING CONNECTED TRANSACTIONS HOTEL MANAGEMENT CONTRACTS AND TRADEMARK LICENSE AGREEMENTS IN RELATION TO HOTELS IN MALAYSIA

23.09.

FE CONSORT INTL (00035): SETTLEMENT OF CONSENT SOLICITATION - U.S.$360,000,000 SENIOR GUARANTEED PERPETUAL CAPITAL NOTES ISSUED BY FEC FINANCE LIMITED ...

19.09.

FE CONSORT INTL (00035): FORM OF ELECTION

17.09.

FE CONSORT INTL (00035): RESULTS OF CONSENT SOLICITATION - U.S.$360,000,000 SENIOR GUARANTEED PERPETUAL CAPITAL NOTES ISSUED BY FEC FINANCE LIMITED AND ...

Zeit	Aktuelle Nachrichten
04.09.	Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Guard Therapeutics International AB	With effect from September 05, 2024, the subscription rights in Guard Therapeutics International AB will be traded on First North Growth Market. Trading will continue up until and including September... ► Artikel lesen
02.09.	XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024	Das Instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024 The instrument MSPA MA0000011488 ITISSALAT AL-MA.... ► Artikel lesen
29.08.	Guard Therapeutics International AB: First patient dosed in Guard Therapeutics' phase 2b study POINTER	Guard Therapeutics today announced that the first patient has been dosed in the phase 2b clinical study POINTER with the drug candidate RMC-035 as a kidney-protective treatment in open-heart surgery. "It... ► Artikel lesen
27.08.	Guard Therapeutics International AB: Guard Therapeutics carries out announced rights issue (repair issue)	THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, DISTRIBUTED OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA... ► Artikel lesen
15.12.23	XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 15.12.2023	The following instruments on XETRA do have their first trading 15.12.2023 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 15.12.2023 Aktien 1 CA02255Q2099 Alvopetro Energy Ltd. 2... ► Artikel lesen

Zeit

Aktuelle Nachrichten

04.09.

Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Guard Therapeutics International AB

With effect from September 05, 2024, the subscription rights in Guard Therapeutics International AB will be traded on First North Growth Market. Trading will continue up until and including September...
► Artikel lesen

02.09.

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024

29.08.

Guard Therapeutics International AB: First patient dosed in Guard Therapeutics' phase 2b study POINTER

Guard Therapeutics today announced that the first patient has been dosed in the phase 2b clinical study POINTER with the drug candidate RMC-035 as a kidney-protective treatment in open-heart surgery. "It...
► Artikel lesen

27.08.

Guard Therapeutics International AB: Guard Therapeutics carries out announced rights issue (repair issue)

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, DISTRIBUTED OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA...
► Artikel lesen

15.12.23

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 15.12.2023

The following instruments on XETRA do have their first trading 15.12.2023 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 15.12.2023 Aktien 1 CA02255Q2099 Alvopetro Energy Ltd. 2...
► Artikel lesen

Zeit	Aktuelle Nachrichten
02.09.	XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024	Das Instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024 The instrument MSPA MA0000011488 ITISSALAT AL-MA.... ► Artikel lesen
10.07.	The Court's Response to Maroc Telecom's Appeal Hinders the Success of e&'s Investments in Morocco	ABU DHABI, UAE, July 10, 2024 /PRNewswire/ -- e& Group has expressed its disappointment with the Court of Appeal of Casablanca's decision on 3 July 2024, which rejected the appeal filed by... ► Artikel lesen
03.07.	Moroccan appeals court upholds fine on Maroc Telecom in antitrust case

Zeit

Aktuelle Nachrichten

02.09.

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024

10.07.

The Court's Response to Maroc Telecom's Appeal Hinders the Success of e&'s Investments in Morocco

ABU DHABI, UAE, July 10, 2024 /PRNewswire/ -- e& Group has expressed its disappointment with the Court of Appeal of Casablanca's decision on 3 July 2024, which rejected the appeal filed by...
► Artikel lesen

03.07.

Moroccan appeals court upholds fine on Maroc Telecom in antitrust case

Zeit	Aktuelle Nachrichten
Do	Matinas BioPharma mulls wind-down as antifungal therapy deal falls through
Do	Matinas BioPharma plunges as deal for lead asset falls apart
Do	Matinas BioPharma Holdings, Inc.: Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction	BEDMINSTER, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sheet regarding... ► Artikel lesen
Do	Matinas BioPharma Holdings, Inc. - 8-K, Current Report
Di	MTNB-Aktie erreicht 52-Wochen-Tief bei 2,87 US-Dollar

Zeit

Aktuelle Nachrichten

Matinas BioPharma mulls wind-down as antifungal therapy deal falls through

Matinas BioPharma plunges as deal for lead asset falls apart

Matinas BioPharma Holdings, Inc.: Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction

BEDMINSTER, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sheet regarding...
► Artikel lesen

Matinas BioPharma Holdings, Inc. - 8-K, Current Report

MTNB-Aktie erreicht 52-Wochen-Tief bei 2,87 US-Dollar

Zeit	Aktuelle Nachrichten
04.09.	AIM - Cancellation - MATTIOLI WOODS PLC
03.09.	Mattioli Woods PLC - Scheme Effective
03.09.	AIM - Suspension - Mattioli Woods plc
02.09.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.09.2024	The following instruments on Boerse Frankfurt do have their last trading day on 02.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.09.2024ISIN NameBE0003846632 OXURION... ► Artikel lesen
02.09.	XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024	Das Instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024 The instrument MSPA MA0000011488 ITISSALAT AL-MA.... ► Artikel lesen

Zeit

Aktuelle Nachrichten

04.09.

AIM - Cancellation - MATTIOLI WOODS PLC

03.09.

Mattioli Woods PLC - Scheme Effective

03.09.

AIM - Suspension - Mattioli Woods plc

02.09.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.09.2024

The following instruments on Boerse Frankfurt do have their last trading day on 02.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.09.2024ISIN NameBE0003846632 OXURION...
► Artikel lesen

02.09.

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024

Zeit	Aktuelle Nachrichten
11.10.	Oruka draws buy at Stifel on potential against psoriasis
10.10.	Stifel sets $49 target on Oruka Therapeutics, cites innovation
10.10.	Stifel setzt 49 US-Dollar Kursziel für Oruka Therapeutics, betont Innovation
07.10.	Oruka Therapeutics-Aktien erhalten Kaufempfehlung: H.C. Wainwright sieht vielversprechende Zukunft in der Psoriasis-Behandlung
07.10.	Oruka Therapeutics shares gain buy rating as H.C. Wainwright sees strong future in psoriasis treatment

Zeit

Aktuelle Nachrichten

11.10.

Oruka draws buy at Stifel on potential against psoriasis

10.10.

Stifel sets $49 target on Oruka Therapeutics, cites innovation

10.10.

Stifel setzt 49 US-Dollar Kursziel für Oruka Therapeutics, betont Innovation

07.10.

Oruka Therapeutics-Aktien erhalten Kaufempfehlung: H.C. Wainwright sieht vielversprechende Zukunft in der Psoriasis-Behandlung

07.10.

Oruka Therapeutics shares gain buy rating as H.C. Wainwright sees strong future in psoriasis treatment

Zeit	Aktuelle Nachrichten
Di	OXURION: Oxurion NV: Key developments and timeline for current the potential acquisition	Oxurion NV: Belangrijkste ontwikkelingen en lijn met betrekking tot de lopende potentiële overname LEUVEN, BELGIË - 29 oktober 2024 - 22u00 CET, Oxurion NV (Euronext Brussels: OXUR), een biofarmaceutisch... ► Artikel lesen
24.10.	OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC	Leuven, BELGIUM - October 24, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen
14.10.	OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC	Leuven, BELGIUM - October 14, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen
10.10.	OXURION: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas	Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital... ► Artikel lesen
02.10.	OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC	Leuven, BELGIUM - October 2, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen

Zeit

Aktuelle Nachrichten

OXURION: Oxurion NV: Key developments and timeline for current the potential acquisition

Oxurion NV: Belangrijkste ontwikkelingen en lijn met betrekking tot de lopende potentiële overname LEUVEN, BELGIË - 29 oktober 2024 - 22u00 CET, Oxurion NV (Euronext Brussels: OXUR), een biofarmaceutisch...
► Artikel lesen

24.10.

OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Leuven, BELGIUM - October 24, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

14.10.

OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Leuven, BELGIUM - October 14, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

10.10.

OXURION: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital...
► Artikel lesen

02.10.

OXURION: Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC

Leuven, BELGIUM - October 2, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Fr	XTEP INT'L (01368): (1) COMPLETION OF ISSUE OF XTEP CONVERTIBLE BONDS; (2) COMPLETION OF EARLY REDEMPTION OF K-SWISS CONVERTIBLE BONDS BY KP GLOBAL AND ...
Mi	XTEP INT'L (01368): NEXT DAY DISCLOSURE RETURNS
Mi	XTEP INT'L (01368): ADJUSTMENT TO CONVERSION PRICE OF THE CONVERTIBLE BONDS
23.10.	Core XTEP INT'L Brand 3Q Retail Sell-through Records Mid-single Digit YoY Growth
23.10.	XTEP INT'L (01368): OPERATIONAL UPDATE ON BUSINESS IN MAINLAND CHINA FOR THE THIRD QUARTER OF 2024

Zeit

Aktuelle Nachrichten

XTEP INT'L (01368): (1) COMPLETION OF ISSUE OF XTEP CONVERTIBLE BONDS; (2) COMPLETION OF EARLY REDEMPTION OF K-SWISS CONVERTIBLE BONDS BY KP GLOBAL AND ...

XTEP INT'L (01368): NEXT DAY DISCLOSURE RETURNS

XTEP INT'L (01368): ADJUSTMENT TO CONVERSION PRICE OF THE CONVERTIBLE BONDS

23.10.

Core XTEP INT'L Brand 3Q Retail Sell-through Records Mid-single Digit YoY Growth

23.10.

XTEP INT'L (01368): OPERATIONAL UPDATE ON BUSINESS IN MAINLAND CHINA FOR THE THIRD QUARTER OF 2024

Unternehmen / Aktien	Kurs	%
ENERGY RESOURCES OF AUSTRALIA LIMITED	0,002	0,00 %
FAR EAST CONSORTIUM INTERNATIONAL LTD	0,115	-2,54 %
GUARD THERAPEUTICS INTERNATIONAL AB	2,000	0,00 %
MAROC TELECOM	7,950	-4,22 %
MATINAS BIOPHARMA HOLDINGS INC	0,580	-7,18 %
MATTIOLI WOODS PLC	9,250	0,00 %
ORUKA THERAPEUTICS INC	25,200	-3,08 %
OXURION NV	0,285	0,00 %
XTEP INTERNATIONAL HOLDINGS LTD	0,675	+3,05 %

Unternehmen / Aktien

Kurs

ENERGY RESOURCES OF AUSTRALIA LIMITED

0,002

0,00 %

FAR EAST CONSORTIUM INTERNATIONAL LTD

0,115

-2,54 %

GUARD THERAPEUTICS INTERNATIONAL AB

2,000

0,00 %

MAROC TELECOM